ARTICLE | Distillery Therapeutics
Cancer
December 5, 2017 7:29 PM UTC
Patient and mouse studies suggest inhibiting FBXO32 could help treat metastatic breast cancer. In patient tumor samples, FBXO32 expression was higher in invasive tumors than in non-invasive tumors. In...
BCIQ Company Profiles
BCIQ Target Profiles